NCT00220363View on ClinicalTrials.gov

A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2004

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Overactive Bladder Syndrome
Interventions
DRUG

SPM 907

Trial Locations (1)

Unknown

Schwarz, Monheim

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY